Topics:
Thoracic Malignancies • Medical Oncology
Would you offer Durvalumab as consolidation therapy to a patient with stage III NSCLC but had local recurrence treated with definitive SBRT?
Prior to the PACIFIC trial, patients were treated with definitive chemo/rads. With local recurrence <1yr after chemorads and definitive treatment for local recurrence with SBRT, would it be reasonable to start Durvalumab?
Answer from: Medical Oncologist at Academic Institution
This very relevant and highly challenging question brings to mind Osler’s quote: "Medicine is a science of uncertainty and an art in probability". How do we apply the data that we have to the individual patient in front of us needing our best counsel? How do we apply the now more m...
Sign in or Register to read more